169 related articles for article (PubMed ID: 25141076)
1. RandomForest4Life: a Random Forest for predicting ALS disease progression.
Hothorn T; Jung HH
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):444-52. PubMed ID: 25141076
[TBL] [Abstract][Full Text] [Related]
2. Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.
Tang M; Gao C; Goutman SA; Kalinin A; Mukherjee B; Guan Y; Dinov ID
Neuroinformatics; 2019 Jul; 17(3):407-421. PubMed ID: 30460455
[TBL] [Abstract][Full Text] [Related]
3. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
4. A role for functional classification in the early identification of prognostic factors in ALS.
Rauchway AC; Kaiboriboon K; Bansal SK; Kulkantrakorn K; Guo X; Parks BJ; Hayat GR
Amyotroph Lateral Scler; 2007 Aug; 8(4):214-6. PubMed ID: 17653918
[TBL] [Abstract][Full Text] [Related]
5. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients.
Reich-Slotky R; Andrews J; Cheng B; Buchsbaum R; Levy D; Kaufmann P; Thompson JL
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):212-6. PubMed ID: 23452274
[TBL] [Abstract][Full Text] [Related]
6. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
7. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
[TBL] [Abstract][Full Text] [Related]
8. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
Park Y; Park J; Kim Y; Baek H; Kim SH
Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis disease progression model.
Gomeni R; Fava M;
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):119-29. PubMed ID: 24070404
[TBL] [Abstract][Full Text] [Related]
10. Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression.
Karanevich AG; Statland JM; Gajewski BJ; He J
BMC Med Res Methodol; 2018 Feb; 18(1):19. PubMed ID: 29409450
[TBL] [Abstract][Full Text] [Related]
11. Deep learning methods to predict amyotrophic lateral sclerosis disease progression.
Pancotti C; Birolo G; Rollo C; Sanavia T; Di Camillo B; Manera U; Chiò A; Fariselli P
Sci Rep; 2022 Aug; 12(1):13738. PubMed ID: 35962027
[TBL] [Abstract][Full Text] [Related]
12. Measuring function in advanced ALS: validation of ALSFRS-EX extension items.
Wicks P; Massagli MP; Wolf C; Heywood J
Eur J Neurol; 2009 Mar; 16(3):353-9. PubMed ID: 19364363
[TBL] [Abstract][Full Text] [Related]
13. ALSFRS and appel ALS scores: discordance with disease progression.
Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
[TBL] [Abstract][Full Text] [Related]
14. Telephone follow-up for patients with amyotrophic lateral sclerosis.
Mannino M; Cellura E; Grimaldi G; Volanti P; Piccoli F; La Bella V
Eur J Neurol; 2007 Jan; 14(1):79-84. PubMed ID: 17222118
[TBL] [Abstract][Full Text] [Related]
15. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
[TBL] [Abstract][Full Text] [Related]
16. [Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].
Atsuta N; Watanabe H; Ito M; Nakamura R; Senda J; Kato S; Sobue G
Brain Nerve; 2011 May; 63(5):491-6. PubMed ID: 21515929
[TBL] [Abstract][Full Text] [Related]
17. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
[TBL] [Abstract][Full Text] [Related]
18. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
19. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
Cedarbaum JM; Stambler N; Malta E; Fuller C; Hilt D; Thurmond B; Nakanishi A
J Neurol Sci; 1999 Oct; 169(1-2):13-21. PubMed ID: 10540002
[TBL] [Abstract][Full Text] [Related]
20. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
